Influenza Vaccine-Related Symptoms in Infants
Introduction to Vaccine-Related Symptoms
- The American Academy of Pediatrics recommends that influenza vaccine can cause mild flu-like symptoms in infants, but these are typically limited to fever, irritability, and local reactions—the vaccine cannot cause actual influenza infection 1, 2
Common Post-Vaccination Symptoms in Infants
- Injection site pain, tenderness, redness, and swelling are the most common adverse events after TIV administration in infants 1, 4
- Fever occurs in approximately 10-35% of children younger than 2 years within 24 hours after immunization, though it rarely occurs in older children 1, 4
- Drowsiness, irritability, and loss of appetite are commonly reported systemic reactions in infants receiving IIV4 (quadrivalent inactivated influenza vaccine) 1
- Mild symptoms including lethargy, nausea, headache, and muscle aches may occur but are less common than local reactions 4
Important Clinical Distinction
- The killed vaccine might theoretically produce mild influenza-like symptoms by inducing some of the same cytokines associated with influenza disease, but this is fundamentally different from actual influenza infection 3
- Symptoms are self-limited and typically resolve within 24-48 hours 1, 4
- Symptoms are much milder than actual influenza illness, which in infants can present with high fever, febrile seizures, and signs mimicking bacterial sepsis 3
- Symptoms are not contagious, unlike actual influenza infection 3
Special Consideration: Febrile Seizures
- Febrile seizures can occur after influenza vaccination in young children, particularly when TIV is administered concomitantly with PCV13 or DTaP vaccines 1
- The maximum additional risk is approximately 30 febrile seizure cases per 100,000 children vaccinated when vaccines are given simultaneously 1
- The benefits of timely vaccination outweigh this small risk, as febrile seizures rarely have long-term sequelae, and the alternative—actual influenza infection—carries much higher morbidity and mortality 1, 2
- Routine use of antipyretic agents to prevent febrile seizures is not recommended, as they do not reduce incidence 2